Skip to content

PTC Therapeutics PTCT Federal taxes

Federal taxes at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$242.23M
Insmed logo
InsmedINSM
$0

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$6.55B+40.3%
Enterprise value$6.11B+77.3%
P/E
P/S7.9×+5.3×

Profitability

See full
Gross margin96%
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%
Debt / equity372.3×
Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxPaidFederalAfterRefundReceived.

The official record: PTC Therapeutics’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's federal taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTC Therapeutics's federal taxes?
PTC Therapeutics (PTCT) reported federal taxes of $6.66M in Q4 2025.
What does federal taxes mean?
The actual cash outflow for federal income taxes paid to the national government during the period, net of any refunds received. This metric provides insight into the company's cash tax burden versus its accounting tax provision. It is a critical component for assessing cash flow generation and tax efficiency.